ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first quarter ended September 30, 2016.
The company’s first-quarter revenues were $49.8 million, a 14% increase from the first quarter of fiscal 2016. Coronary revenues grew 33% over last year, while peripheral revenue resumed year-over-year growth, increasing 9%.
